Percutaneous revascularization for ischemic nephropathy: the past, present, and future.

Kidney Int · 2013 · PMC3532568 · PMID 23151953

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

marginally significantno p-value reported

It is important for clinicians evaluating these trials to recognize that entry criteria for many of these trials were based on marginally significant vascular occlusion for many participants.

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.